Pericardial Effusion: Clinical Trials

3 trials for Pericardial Effusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Unknown 2, Completed 1

Follow Pericardial Effusion: new trials by email Literature Review of Pericardial Effusion trials Research Report on Pericardial Effusion

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IMPI 2 - A Trial of Intrapericardial Alteplase in Large Pericardial Effusion
Pericardiocentesis with Alteplase, Conventional Pericardiocentesis - Pericardial Effusion
Phase 3UnknownUniversity of Cape Town21762016-02-012018-05-02
COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)
Colchicine, Placebo - Cardiac Surgery, Post-pericardiotomy Syndrome
Phase 3UnknownMaria Vittoria Hospital3602012-03-012014-07-01
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Paclitaxel, NOV-002, Carboplatin - Non Small Cell Lung Cancer
Phase 3CompletedCellectar Biosciences, Inc.9032006-11-012022-07-25

Narrower conditions

Atrial Fibrillation (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Pleural Effusion (1)  ·  Postpericardiotomy Syndrome (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Respiratory Tract Diseases (2)  ·  Arrhythmias, Cardiac (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pleural Diseases (1)  ·  Postoperative Complications (1)  ·  Respiratory Tract Neoplasms (1)

Interventions

Albumin-Bound Paclitaxel (1)  ·  Carboplatin (1)  ·  Colchicine (1)  ·  NOV 002 (1)  ·  Paclitaxel (1)  ·  Pericardiocentesis (1)  ·  Tissue Plasminogen Activator (1)

Sponsors

Cellectar Biosciences, Inc. (1)  ·  Maria Vittoria Hospital (1)  ·  University of Cape Town (1)

Countries

Italy (2)  ·  Canada (1)  ·  Israel (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Serbia (1)  ·  South Africa (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Ukraine (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Bongani M Mayosi, DPhil (1)  ·  Panos Fidias, MD (1)  ·  Thomas Lynch, MD (1)

Results publications

PMID 23816016, PMID 25172965